Yearly Archives: 2024

Following discussions with Community Pharmacy England, NHS England has published the service specification for the 2024/25 Community Pharmacy Seasonal Influenza Vaccination Advanced Service. This early publication aims to support the planning and provision of the service by pharmacy owners and will assist any service providers should an autumn COVID-19 vaccination service be considered, as any [...]

The post Flu vac: NHSE publishes 2024/25 service spec appeared first on Community Pharmacy England.

We are continuing to liaise with NHS England (which can provide advice to ICBs on market entry issues) and PCSE to try to help reduce the overall timescales for the determination of applications. We have produced a guidance document with 10 key points to support applicants and their referees with their market entry applications. We [...]

The post Market Entry Applications – 10 Key Points Guidance appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Levemir InnoLet® (insulin detemir) 100units/ml solution for injection 3ml pre-filled disposable devices. MSN/2024/033 Tier 2 – medium impact Date of issue: 21st March 2024 Levemir® InnoLet® (insulin detemir) 100units/ml solution for injection 3ml pre-filled disposable devices are being discontinued with remaining [...]

The post Medicine Supply Notification: Levemir InnoLet® (insulin detemir) 100units/ml solution for injection 3ml pre-filled disposable devices appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Insulatard® InnoLet® (insulin isophane human) 100units/ml suspension for injection 3ml pre-filled disposable devices MSN/2024/032 Tier 2 – medium impact Date of issue: 21st March 2024 Insulatard® InnoLet® (insulin isophane human) 100units/ml suspension for injection 3ml pre-filled disposable devices are being discontinued [...]

The post Medicine Supply Notification: Insulatard® InnoLet® (insulin isophane human) 100units/ml suspension for injection 3ml pre-filled disposable devices appeared first on Community Pharmacy England.

Class 4 Medicines Defect Information: Sodium Chloride Intravenous Infusion 0.9% Freeflex (Fresenius Kabi Limited) Drug alert number: EL (24)A/10 Date issued: 21 March 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Sodium Chloride Intravenous Infusion 0.9% Freeflex (Fresenius Kabi Limited) Company name: Fresenius Kabi [...]

The post MHRA Class 4 Medicines Notification: Sodium Chloride Intravenous Infusion 0.9% Freeflex (Fresenius Kabi Limited) appeared first on Community Pharmacy England.